ASO Author Reflections: Systemic Immune-Inflammation Index (SII) as a Biomarker of Response to Neoadjuvant Therapy in Patients with Pancreatic Adenocarcinoma.

ASO Author Reflections: Systemic Immune-Inflammation Index (SII) as a Biomarker of Response to Neoadjuvant Therapy in Patients with Pancreatic Adenocarcinoma. Ann Surg Oncol. 2019 Dec 10;: Authors: Murthy P, Boone BA PMID: 31823171 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31823171?dopt=Abstract

Source: Ann Oncol - December 9, 2019 Category: Cancer & Oncology Authors: Murthy P, Boone BA Tags: Ann Surg Oncol Source Type: research

More News: Adenocarcinoma | Cancer & Oncology | Neoadjuvant Therapy | Pancreas